Ali Ramezani
Impact in
- Nephrology top 5%
- Dialysis and Renal Disease Management
- Virology top 5%
Papers in
-
- CRISPR and Genetic Engineering 16
- RNA Interference and Gene Delivery 10
- Gut microbiota and health 3
- RNA and protein synthesis mechanisms 3
- Genetics 22
- Virus-based gene therapy research 22
- Co-authors
- Robert G. Hawley (24 shared papers)Teresa S. Hawley (9 shared papers)Dominic Raj (1 shared paper)Manuel Velasquez (1 shared paper)Dominic S. Raj (5 shared papers)Ziad A. Massy (1 shared paper)Pieter Evenepoel (1 shared paper)Raymond Vanholder (1 shared paper)
- Journals
- Molecular Therapy (4 papers)Stem Cells (3 papers)Frontiers in bioscience (2 papers)Gene Therapy (2 papers)Current Protocols in Molecular Biology (2 papers)
- Partner nations
- United StatesCanadaIran
In The Last Decade
Ali Ramezani
49 papers receiving 2.1k citations
Ali Ramezani's Hit Papers
Peers
Comparison fields: 5 of 119
- Nephrology 193
- Virology 119
- Genetics 650
- Molecular Biology 1.6k
- Biological Psychiatry 51
Countries citing papers authored by Ali Ramezani
This map shows the geographic impact of Ali Ramezani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Ramezani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Ramezani more than expected).
Fields of papers citing papers by Ali Ramezani
This network shows the impact of papers produced by Ali Ramezani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Ramezani. The network helps show where Ali Ramezani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Ramezani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trimethylamine N-Oxide: The Good, the Bad and the Unknown Hit paper breakdown → | 2016 | 384 |
| 2 | 2015 | 296 | |
| 3 | 2003 | 242 | |
| 4 | 2003 | 127 | |
| 5 | 2007 | 110 | |
| 6 | 2015 | 90 | |
| 7 | 2018 | 71 | |
| 8 | 2001 | 66 | |
| 9 | 2014 | 61 | |
| 10 | 2008 | 54 | |
| 11 | 2017 | 51 | |
| 12 | 2001 | 51 | |
| 13 | 2005 | 41 | |
| 14 | 1993 | 39 | |
| 15 | 2006 | 33 | |
| 16 | 2010 | 33 | |
| 17 | 2002 | 32 | |
| 18 | 2003 | 27 | |
| 19 | 2024 | 27 | |
| 20 | 1996 | 26 |
About Ali Ramezani
Ali Ramezani is a scholar working on Molecular Biology, Genetics, Virology, Oncology and Epidemiology, having authored 50 papers that have together received 2.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (22 papers), CRISPR and Genetic Engineering (16 papers), RNA Interference and Gene Delivery (10 papers), HIV Research and Treatment (9 papers), CAR-T cell therapy research (5 papers), Gut microbiota and health (3 papers), RNA and protein synthesis mechanisms (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Nephrology (193 citations), Virology (119 citations), Genetics (650 citations), Molecular Biology (1.6k citations) and Biological Psychiatry (51 citations). Ali Ramezani has collaborated with scholars based in United States, Canada and Iran. Frequent co-authors include Robert G. Hawley, Teresa S. Hawley, Dominic Raj, Manuel Velasquez, Dominic S. Raj, Ziad A. Massy, Pieter Evenepoel, Raymond Vanholder, Björn Meijers and James A. Thomson. Their work appears in journals such as Molecular Therapy, Stem Cells, Frontiers in bioscience, Gene Therapy and Current Protocols in Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.